Rhode Island legalizes heroin injection sites based on failed Canadian models

According to the proposal, addicts would be able to "safely consume pre-obtained substances" under medical supervision. Advocates claim that injection sites reduce overdose deaths and infectious disease, increase the number of people who seek addiction treatment, and do not increase drug trafficking or crime where they are located.

The measure now heads to the desk of Governor Dan McKee.

Proponents of the Rhode Island legislation (2021-H 5245A, 2021-S 0016B), such as the Drug Policy Alliance, specifically cited Canada's injection sites as a model to replicate.

But according to new studies and data, these sites do the exact opposite of harm reduction. A bombshell study by the Alberta government was released in 2020 on the province's Safe Consumption Sites (SCS), their term for heroin injection sites, which disproved the long adhered to talking points of SCS supporters.

Calls to police to report criminal activity increased near safe consumption sites. Local residents complained about lack of response to calls for police service, as well as "de-policing" near the sites.

There was an increase in needle debris on public and private property where SCS sites were located. This was a major concern for those who lived nearby, and helped create a perception among community members that the sites both decreased safety and increased crime.

Sen. Miller, who chairs the Senate Committee on Health and Human Services in Rhode Island said, "People who are addicted need help and protection from the most dangerous possibilities of addiction. Having a place where someone can save them from an overdose and where there are people offering them the resources they need for treatment is a much better alternative to people dying alone in their homes or their cars."

The Alberta study debunked these claims.

"While there were no deaths recorded among people who used drugs at the SCS sites," the report added, "...death rates in the immediate vicinity of the SCS locations increased. Opioid-related calls for emergency medical services (EMS) also increased in the immediate vicinity following the opening of the sites."

One of the main arguments in support of SCS is that there are no deaths at the sites themselves. While only a doctor or a coroner can declare a person legally dead, there are usually none of these professionals on site.

EMTs can respond to an overdose event at a site and take the person to a hospital where they are declared dead in the emergency room, removing the death event from the location of the site. Alternatively, an overdose victim can be saved by Naloxone on site but refuse further treatment, then leave the facility and die elsewhere. Neither of these deaths would be attributed to the site.

Rhode Island Rep. John G. Edwards said in a news release that "Not only do harm reduction centers severely mitigate the chance of overdose, they are a gateway to treatment and rehabilitation of people with substance abuse disorder." Yet the Alberta study showed the exact opposite: "The Committee became concerned with the lack of focus on referrals to detoxification and treatment resources. Where it was suggested that referrals were made, no evidence was found to support action taken to follow up on such referrals."

"Stakeholder feedback predominantly suggested that the SCS have had a negative social and economic impact on the community."

What is immediately evident is that the amount of crime increased substantially in the area immediate to the SCS. This could also be attributed to the fact that "Site users and operators typically believed that the Section 56.1 exemption allowed for a no-go zone for police within the proximity of the site. Evidence suggested a level of 'de-policing' near some sites."

On the matter of policing, "Police officials indicated that having somewhere to take individuals other than cell blocks would be helpful. They noted that, often, jail was not suitable for these individuals, but that they were not unwell enough for hospital urgent care. Concerns were not limited to drug treatment programs, but were also directed toward obtaining mental health programming, other medical treatment and integration with social services, such as housing, employment and life-skill programs."

Another concern cited in the report was that "Needle debris was a substantial issue with many residents complaining about used and unused needles, broken crack pipes and other drug-related paraphernalia being discarded in the vicinity of the sites and in public areas near the sites."

The report also highlighted the link between addiction and homelessness. "While it is likely that most drug users are not homeless, a significant portion of SCS clients fall within that demographic."

"Many proponents as well as opponents of SCS maintained that much of the perceived social malaise associated with SCS was linked, not just to drug consumption, but also to the consequences of homelessness. In the minds of many citizens, the appearance and especially the location of tent cities was linked to the location of SCS."

The report went on to say that "While most drug users are not homeless or economically marginalized, many drug users fall into that category. To support their use, many turn to marginal or criminal activities to pay for their drug supply. Typically, those activities range from panhandling to theft, robbery, fraud, prostitution or the secondary distribution of illicit substances. Persons selling drugs—drug dealers—will also engage in crimes such as assault or intimidation to collect debts incurred by drug users."

British Columbia, which also has injection sites that have devastated neighborhoods, is on pace to beat last year's record overdose numbers. Though advocates for the injection sites claimed that users would have to bring their own drugs and that narcotics were not provided, Doctors in BC were recently approved to prescribe drugs like hydromorphone, an opioid that is five times more powerful than morphine; Dexedrine, a stimulant for cocaine and methamphetamine users; and tablets of fentanyl, a synthetic opioid.